TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/28/2023
Back to search
Official data from USPTO
AFORTIORI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AFORTIORI
ST13
US500000090893451Class
35, 41, 42, 45
Filing
90893451
Registration
7123887
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
09/28/2023
Classification
Registered
Trademark type
Word
Nice classes
35, 41, 42, 45
Filing date
08/20/2021
Registration date
08/01/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/01/2023
Last transaction
09/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Galway, IE
Examiner
FRENCH, CURTIS W
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Afortiori Development Limited
Representatives
P. Jay Hines MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 35Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business strategy and planning services; expert evaluations and reports relating to business matters; collection and analysis of quality metric data for specialist medical professionals for business purposes; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; data processing; business data analysis in the field of clinical trials; database management; business analysing and compiling of non-technical data in the fields of medicinepharmaceuticalsbiopharmaceuticalsmedical devices and drug approval; business evaluation in the fields of medicinepharmaceuticalsbiopharmaceuticalsmedical devices and drug approval; analysis of business data; analysis of market research data; business research and surveys; conducting surveys for business purposes; market research and analysis; business administration; consultancyinformation and advisory services relating to all of the aforesaid services
Class 41
Publication of on-line reportsarticlesjournals and scientific texts featuring the results of clinical trials; consultancyinformation and advisory services relating to all of the aforesaid services
Class 42
Medical and scientific researchconductingdeveloping and designing clinical trials for others; medical and scientific researchclinical trial monitoring and management services; medical and scientific researchplanningarranging and conducting clinical trials; medical and scientific researchstrategic planning relating to clinical trials; conducting early evaluations in the field of new pharmaceuticals; medical and scientific researchcollection of technical data relating to clinical trialsmedicinepharmaceuticalsbiopharmaceuticalsdrug approvalmedical devices and the development of software applications; evaluation of product development; medical and scientific researchexpert evaluations and reports relating to clinical trials; medical and scientific researchproviding information about the results of clinical trials for pharmaceutical productsincluding biopharmaceuticals and medical devices; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; technical project planning and project management in the fields of medical and scientific researchclinical trialspharmaceuticalsbiopharmaceuticalsdrug approvalmedical devices or software applications; technical analysis and evaluation of clinical reports in the field of medical and scientific research; technical statistical analysis in the field of medical and scientific research; analysismanagement and review of technical data in the fields of medical and scientific researchclinical trialspharmaceuticalsbiopharmaceuticalsdrug approvalmedical devices or software applications; technical testingmeasuringsurvey and evaluation services; pharmaceutical product evaluation; analysis of product development; expert evaluations and reports relating to technical matters in the fields of medical and scientific researchclinical trialspharmaceuticalsbiopharmaceuticalsdrug approvalmedical devices or software applications; database design; maintenance of on-line databases for others; online electronic data storage; measurement evaluation services in the field of medical and scientific research; providing quality assurance services in the fields of medical and scientific researchclinical trialspharmaceuticalsbiopharmaceuticalsdrug approvalmedical devices or software applications; quality management servicesquality evaluation and analysisquality assurancequality controlin the field of medical sciencescientific research and medical consultancy; consulting services for others in the field of designplanning and implementation project management of scientific research or clinical trials
Class 45
Advisory services relating to regulatory affairsregulatory compliance consulting in the field of pharmaceuticalsbiopharmaceuticalsdrug approvalclinical trialsmedicines or medical devices; reviewing standards and practices to assure compliance with laws and regulations; regulatory compliance auditing; consultancyinformation and advisory services relating to all of the aforesaid services
Publications
History of USPTO decisions and trademark events.
30 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/28/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/28/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/01/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/01/2023
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
06/28/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/23/2023
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
05/23/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/23/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/28/2023
PUBO
PUBLISHED FOR OPPOSITION
03/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/08/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
02/23/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/17/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/06/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/10/2022
GNSL
LETTER OF SUSPENSION E-MAILED
10/10/2022
CNSL
SUSPENSION LETTER WRITTEN
10/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/24/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/25/2022
GNRT
NON-FINAL ACTION E-MAILED
05/25/2022
CNRT
NON-FINAL ACTION WRITTEN
05/25/2022
DOCK
ASSIGNED TO EXAMINER
05/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2021
NWAP
NEW APPLICATION ENTERED
08/24/2021
Continuous trademark protection
Get notified about every new filing that threatens AFORTIORI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.